Trial intelligence / Profile preview

Flurbiprofen Patches vs Flurbiprofen Cataplasm and Placebo in Knee Osteoarthritis

CTR20233164Phase 3Completed

Sponsor
九典制药
Start
Oct 2023
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of flurbiprofen in knee osteoarthritis (OA), sponsored by 九典制药. Started Oct 2023; status: completed.

02

Drugs

flurbiprofen
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on CTR20233164.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20233164.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call